Incannex Healthcare Announces Formation of Clinical Advisory Board for PSX-001 Program

Stock Information for iQSTEL Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About iQSTEL Inc.

Incannex Reactivates Share Repurchase Program, Underscoring Confidence in Valuation and Strategic Position
Incannex Healthcare Announces Partnership with the AASM Foundation in Support of Sleep Apnea Research
Incannex Highlights Strong Balance Sheet with Approximately $75 Million in Cash and No Debt as Company Advances IHL-42X Development
Incannex Regains Compliance with Nasdaq Minimum Bid Price Requirement
Incannex Healthcare Inc. Announces Pricing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Incannex Strengthens Clinical Development Pathway for IHL-42X Following Positive Phase 2 Outcomes
Incannex Announces Reverse Stock Split
Incannex Healthcare Announces Additional Appointments to Clinical Advisory Board

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.